增强益生菌细胞外囊泡生产的生物处理策略:培养条件调制培养条件调制
Qingyu Lei1, Shiva Kamini Divakarla1,2, Tristrom Winsley2
1Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, VIC, Australia.
Frontiers in bioengineering and biotechnology
|September 16, 2024
概括
生物制造益生菌细胞外囊泡 (LREVs) 需要优化培养条件. 调整pH值,生长时间和度会影响LREV产量和功能,从而产生潜在的治疗应用.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 细胞外囊泡 细胞外囊泡
背景情况:
- 益生菌细菌,比如乳杆菌种类. *,以其健康益处而闻名.
- 与益生菌相比,益生菌细胞外囊泡 (LREVs) 显示出优越的免疫调节能力.
- 了解LREV生产机制对于利用其治疗潜力至关重要.
研究的目的:
- 研究生物制造过程参数如何影响LREV产量和生物功能.
- 为了确定培养微环境对LREV特征的影响.
- 评估LREVs在治疗皮肤疾病方面的潜力.
主要方法:
- 为LREV生产而选择的 *Lacticaseibacillus rhamnosus*.
- 系统调节培养的pH值,生长时间和度.
- 分析了LREV关键质量属性 (CQAs) 和对角质细胞和黄金葡萄球菌 (Staphylococcus aureus) 的功能影响.
主要成果:
- LREV的生产和组成受到环境压力 (pH,度,生长时间) 的显著影响.
- LREVs证明对人类表皮角质细胞无毒性.
- 这种LREVs表现出对*黄金葡萄球菌*的抗菌特性.
结论:
- 优化生物制造条件是控制LREV特征的关键.
- LREVs在治疗皮肤疾病,如受感染的伤口方面表现有前途.
- 量身定制的LREV生产可以实现各种医疗和工业应用.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Fed-Batch Culture
Fed-batch culture is a widely used bioprocessing strategy combining aspects of batch culture with controlled substrate feeding to optimize cell growth and product formation. In this semi-closed system, nutrients are strategically added during fermentation, while the accumulated products and biomass remain within the bioreactor until the end of the operation. This controlled addition of substrates allows for better management of growth kinetics, nutrient limitation, and metabolite...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...


